154 related articles for article (PubMed ID: 9816012)
1. Cell kinetics of head and neck cancers.
Kotelnikov VM; Coon JS IV; Haleem A; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Griem K; Preisler HD
Clin Cancer Res; 1995 May; 1(5):527-37. PubMed ID: 9816012
[TBL] [Abstract][Full Text] [Related]
2. [The in vivo use of bromodeoxyuridine for the study of cell kinetics in squamous tumors of the neck and head. Implications for the radiotherapist].
Corvò R; Giaretti W; Margarino G; Danova M; Vitale V
Radiol Med; 1991; 82(1-2):147-52. PubMed ID: 1896568
[TBL] [Abstract][Full Text] [Related]
3. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
[TBL] [Abstract][Full Text] [Related]
4. Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.
Preisler HD; Kotelnikov VM; LaFollette S; Taylor S; Mundle S; Wood N; Coon JS; Hutchinson J; Panje W; Caldarelli DD; Griem K
Clin Cancer Res; 1996 Sep; 2(9):1453-60. PubMed ID: 9816320
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of epithelia of noninvolved mucosa in patients with head and neck cancer.
Kotelnikov VM; Coon JS; Taylor S; Hutchinson J; Panje W; Caldareill DD; LaFollette S; Preisler HD
Head Neck; 1996; 18(6):522-8. PubMed ID: 8902565
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic role of the parameters of cellular kinetics in head and neck tumors treated solely by radiotherapy].
Corvò R; Giaretti W; Sanguineti G; Geido E; Bacigalupo A; Franzone P; Mereu P; Garaventa G; Barbieri M; Vitale V
Radiol Med; 1993; 86(1-2):135-42. PubMed ID: 8346344
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
Kotelnikov V; Cass L; Coon JS; Spaulding D; Preisler HD
Clin Cancer Res; 1997 May; 3(5):669-73. PubMed ID: 9815735
[TBL] [Abstract][Full Text] [Related]
8. Cell kinetics of glial tumors.
Hoshino T
Rev Neurol (Paris); 1992; 148(6-7):396-401. PubMed ID: 1448658
[TBL] [Abstract][Full Text] [Related]
9. Rapid tumor cell proliferation after induction chemotherapy in oropharyngeal cancer.
Bourhis J; Wilson G; Wibault P; Janot F; Bosq J; Armand JP; Luboinski B; Malaise EP; Eschwege F
Laryngoscope; 1994 Apr; 104(4):468-72. PubMed ID: 8164487
[TBL] [Abstract][Full Text] [Related]
10. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
[TBL] [Abstract][Full Text] [Related]
11. A novel triple label method validates the double label technique of defining cell cycle kinetics in HL-60 cells.
Mehdi A; Bokhari SA; Yousuf N; Umerani A; Chughtai S; Hussain F; Raza A
Anticancer Res; 1992; 12(5):1443-6. PubMed ID: 1444205
[TBL] [Abstract][Full Text] [Related]
12. In vivo cell kinetics in elderly patients affected by squamous cell carcinoma of the head and neck.
Corvò R; Sanguineti G; Vitale V; Bacigalupo A; Margarino G; Benasso M; Numico GM; Giaretti W
Rays; 1997; 22(1 Suppl):69-72. PubMed ID: 9250019
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading.
Johnson TS; Williamson KD; Cramer MM; Peters LJ
Cytometry; 1985 Sep; 6(5):461-70. PubMed ID: 4042786
[TBL] [Abstract][Full Text] [Related]
14. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
Hass HG; Schmidt A; Nehls O; Kaiser S
Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
[TBL] [Abstract][Full Text] [Related]
15. Tumor cell kinetics using two labels and flow cytometry.
Ritter MA; Fowler JF; Kim YJ; Gilchrist KW; Morrissey LW; Kinsella TJ
Cytometry; 1994 May; 16(1):49-58. PubMed ID: 8033734
[TBL] [Abstract][Full Text] [Related]
16. [Proliferation kinetics of human brain tumors by in situ double labeling with bromodeoxyuridine and iododeoxyuridine].
Maeda T; Hoshino T
No To Shinkei; 1992 Sep; 44(9):821-5. PubMed ID: 1476811
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer.
Edström S; Cvetkovska E; Westin T; Young C
Laryngoscope; 2001 Jan; 111(1):124-30. PubMed ID: 11192880
[TBL] [Abstract][Full Text] [Related]
18. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
Meyer JS; Gersell DJ; Yim S
Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
[TBL] [Abstract][Full Text] [Related]
19. [The effect of the microenvironment of head and neck cancers on tumor progression].
Lukits J
Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
[TBL] [Abstract][Full Text] [Related]
20. [Immunohistochemical results obtained with bromodeoxy uridine (BUdR) labelled tumors of the head and neck].
Radner H; Kärcher H
Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(2):116-21. PubMed ID: 2102412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
